ADRB1 and heart failure: Based on that, it has been suggested a promising therapeutic strategy to treat heart failure based on long-term β3AR stimulation that would protect against the adverse remodelling mainly mediated by β1AR response to the increased sympathetic activity (Engelhardt et al., 1999; Cannavo and Koch, 2017).